A Dose-escalation Phase I Trial of PD-1 Knockout Engineered T Cells for the Treatment of Muscle-invasive Bladder Cancer
NCT02863913 · WITHDRAWN · Phase 1
ReadTheTrial indexes 1 studies for Invasive Bladder Cancer Stage Iv. The most common development stage is Phase 1 (1 trials). Each trial page translates ClinicalTrials.gov eligibility, outcomes, and design into patient-friendly language so you can compare options quickly.
1 clinical trials found for Invasive Bladder Cancer Stage Iv.
| Phase | Trials | Distribution |
|---|---|---|
| Phase 1 | 1 | 100% |
There are 1 clinical trials listed for Invasive Bladder Cancer Stage Iv. These span various phases from early safety studies to post-approval monitoring. Browse the trial listings below for details.
Look for trials with "Recruiting" status in the listings below, or visit our recruiting page to filter by condition. Each trial page includes decoded eligibility criteria to help you determine if you qualify.
Current Invasive Bladder Cancer Stage Iv trials are distributed across: Phase 1 (1).